152 related articles for article (PubMed ID: 14697341)
1. Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis.
Renous R; Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
Exp Cell Res; 2004 Jan; 292(2):332-41. PubMed ID: 14697341
[TBL] [Abstract][Full Text] [Related]
2. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis.
Lapierre P; Hajoui O; Homberg JC; Alvarez F
Gastroenterology; 1999 Mar; 116(3):643-9. PubMed ID: 10029623
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis.
Lapierre P; Johanet C; Alvarez F
Eur J Immunol; 2003 Jul; 33(7):1869-78. PubMed ID: 12811847
[TBL] [Abstract][Full Text] [Related]
4. Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1.
Muratori L; Sztul E; Muratori P; Gao Y; Ripalti A; Ponti C; Lenzi M; Landini MP; Bianchi FB
Hepatology; 2001 Sep; 34(3):494-501. PubMed ID: 11526534
[TBL] [Abstract][Full Text] [Related]
5. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection.
Béland K; Lapierre P; Marceau G; Alvarez F
J Autoimmun; 2004 Mar; 22(2):159-66. PubMed ID: 14987745
[TBL] [Abstract][Full Text] [Related]
6. Structure of the bifunctional and Golgi-associated formiminotransferase cyclodeaminase octamer.
Mao Y; Vyas NK; Vyas MN; Chen DH; Ludtke SJ; Chiu W; Quiocho FA
EMBO J; 2004 Aug; 23(15):2963-71. PubMed ID: 15272307
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune hepatitis: evolving concepts.
Diamantis I; Boumpas DT
Autoimmun Rev; 2004 Mar; 3(3):207-14. PubMed ID: 15110233
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
9. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.
Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L
Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein.
Vitozzi S; Lapierre P; Djilali-Saiah I; Alvarez F
J Immunol Methods; 2002 Apr; 262(1-2):103-10. PubMed ID: 11983223
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
12. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
[TBL] [Abstract][Full Text] [Related]
13. A formiminotransferase cyclodeaminase isoform is localized to the Golgi complex and can mediate interaction of trans-Golgi network-derived vesicles with microtubules.
Hennig D; Scales SJ; Moreau A; Murley LL; De Mey J; Kreis TE
J Biol Chem; 1998 Jul; 273(31):19602-11. PubMed ID: 9677386
[TBL] [Abstract][Full Text] [Related]
14. Localization of Golgi 58K protein (formiminotransferase cyclodeaminase) to the centrosome.
Hagiwara H; Tajika Y; Matsuzaki T; Suzuki T; Aoki T; Takata K
Histochem Cell Biol; 2006 Aug; 126(2):251-9. PubMed ID: 16534631
[TBL] [Abstract][Full Text] [Related]
15. A novel type of regulation of the vimentin intermediate filament cytoskeleton by a Golgi protein.
Gao YS; Vrielink A; MacKenzie R; Sztul E
Eur J Cell Biol; 2002 Jul; 81(7):391-401. PubMed ID: 12160147
[TBL] [Abstract][Full Text] [Related]
16. 58K, a microtubule-binding Golgi protein, is a formiminotransferase cyclodeaminase.
Bashour AM; Bloom GS
J Biol Chem; 1998 Jul; 273(31):19612-7. PubMed ID: 9677387
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, characterization, and dynamics of rat formiminotransferase cyclodeaminase, a Golgi-associated 58-kDa protein.
Gao YS; Alvarez C; Nelson DS; Sztul E
J Biol Chem; 1998 Dec; 273(50):33825-34. PubMed ID: 9837973
[TBL] [Abstract][Full Text] [Related]
18. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
[TBL] [Abstract][Full Text] [Related]
19. Type 2 autoimmune hepatitis: Genetic susceptibility.
Lapierre P; Alvarez F
Front Immunol; 2022; 13():1025343. PubMed ID: 36248826
[TBL] [Abstract][Full Text] [Related]
20. Autoimmmune hepatitis.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
Cell Mol Immunol; 2022 Feb; 19(2):158-176. PubMed ID: 34580437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
